When Wegovy Stops Suppressing Your Appetite: Myth, Reality and What Actually Helps

The biggest misconception: reduced appetite suppression does not equal treatment failure

Most people who contact their clinic or search this question believe the medicine has stopped working entirely. That framing is almost always wrong. Semaglutide continues to act on GLP-1 receptors in the brain and gut regardless of what appetite feels like on a given day or week. What changes is the intensity of the signal, not its presence.

The most noticeable appetite suppression typically occurs in the 24 to 48 hours after an injection, and in the first two to four weeks after moving up to a new dose. Once your body has equilibrated at a dose, the dramatic reduction in hunger tends to settle into something quieter, still there, but less striking. People sometimes misread that settling as the medicine stopping. It has not. The way semaglutide suppresses appetite is not designed to feel dramatic indefinitely; it is designed to shift your baseline over time.

That said, there is a real and important distinction between the normal plateau described above and a genuine, sustained loss of appetite suppression. If you are finding that there is no appetite suppression on Wegovy for several weeks and weight loss has stalled, that deserves a proper clinical conversation. A prescriber can review your dose, assess what else might be contributing, and decide whether anything needs to change. The answer is rarely to simply push on.

What else is driving appetite when the medicine seems less effective

Wegovy lowers appetite partly by slowing gastric emptying and partly through central nervous system pathways that regulate food-seeking behaviour. Both mechanisms can be counteracted by factors that have nothing to do with the medicine's efficacy.

Poor sleep is one of the most consistent culprits. Even a few nights of disrupted rest can raise ghrelin (the hunger hormone) and reduce satiety signalling, making appetite feel far more urgent than it would otherwise. Chronic stress works similarly, cortisol drives a preference for energy-dense foods and can override the quieter satiety signals that semaglutide produces.

Food choice matters too. Ultra-processed foods with rapidly absorbed refined carbohydrates cause sharp blood sugar swings that reignite hunger within hours. The foods you eat on Wegovy interact directly with how pronounced the appetite-suppressing effect feels day to day. Protein and fibre extend satiety in a way that complements how the medicine works; a breakfast built around them tends to hold appetite through to lunch far more reliably than toast or cereal alone.

Hormonal changes (including the menstrual cycle, perimenopause and thyroid fluctuations) can produce week-to-week variation in appetite that sits on top of whatever the medicine is doing. These are normal and do not mean the treatment is failing; they mean appetite is complex.

Missed doses, dose reductions and what happens to hunger

If you have missed an injection or recently stepped down from a higher dose, returning appetite is essentially guaranteed and is the expected pharmacological response. Semaglutide has a half-life of approximately one week, so a missed dose means circulating levels begin to fall meaningfully within days. Hunger often returns well before the next scheduled injection is due, particularly at lower doses where the suppression was less robust to begin with.

This is a question our prescribers hear regularly: people who skipped one pen because they were unwell or travelling, and then concluded the medicine had stopped working when hunger surged back. If you are concerned that Wegovy is not suppressing appetite as it once did, the sequence of events matters, because gaps in dosing disrupt the steady state that the weekly schedule is designed to maintain. When semaglutide's appetite suppression kicks in depends heavily on consistent dosing.

If you have missed a dose and more than five days have passed since the scheduled injection day, the standard guidance is to skip that missed dose and resume on your usual day. For anything more specific to your situation, your prescriber and the patient information leaflet are the right resources, the timing rules exist for good clinical reasons and are not one-size-fits-all.

When to raise it with your prescriber, and how nume can help

Reduced appetite suppression that has persisted for four weeks or more, is not explained by diet, sleep or missed doses, and has coincided with weight regain or stall is a legitimate reason to seek a clinical review. You do not need to wait until your next scheduled check-in to raise it.

The NHS patient information on semaglutide and NHS England's guidance on weight-management injections both underline that these medicines work best alongside active support, not because the medicine is insufficient on its own, but because sleep, diet and stress management all affect how the medicine's effects translate into lived experience.

At nume, aftercare is included as standard: seven days a week, from a clinical team rather than a chatbot. If something feels off with your treatment, the right move is a conversation with a prescriber who can look at your full history. If you are not yet on treatment and want to understand whether Wegovy is appropriate for you, a free consultation with our prescribers is the place to start, reviewed the same day by a GPhC-registered Independent Prescriber. Worth checking what proper clinical oversight actually looks like before you commit to any provider. You can also read more about how Wegovy works and explore our weight-loss treatment options to compare what might suit you best.